Grant supports research on skin injuries caused by chemical threats, aiming to identify commonalities for medical countermeasure development.
Funder: National Institutes of Health
Due Dates: February 16, 2027 (New) | March 16, 2027 (Resubmission/Revision) | June 16, 2027 (New) | July 16, 2027 (Resubmission/Revision) | October 16, 2027 (New) | November 16, 2027 (Resubmission/Revision) | January 7, 2028 (Listing closes)
Funding Amounts: Up to $450,000 in direct costs over three years, with a $225,000 annual limit
Summary: Supports fundamental research into shared mechanisms of chemical skin injuries and therapeutic targets for broadly effective medical countermeasures.
Key Information: Investigators must have no current or prior CCRP support, including CounterACT funding.
This NIH Chemical Countermeasures Research Program (CCRP) initiative supports fundamental research on skin injuries caused by chemicals identified as high-consequence public health threats. Participating institutes are the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Allergy and Infectious Diseases (NIAID). The emphasis is on common injury mechanisms, shared signaling pathways, and potential therapeutic targets for countermeasures effective against multiple chemicals.
The R34 planning mechanism helps investigators with wound-healing experience enter chemical countermeasure research. Projects may develop laboratory expertise, establish relationships with certified toxic-chemical facilities, and generate preliminary data for more comprehensive research. Relevant work explores local and systemic mechanisms of chemical wound development, healing, and long-term consequences, including injuries from vesicants and toxic industrial or corrosive chemicals.